| Financial Year |
March 31 2023 |
| Monetary Funds |
245,291,967.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
182,701,584.75 |
| Accounts Receivable |
77,041,794.58 |
| Advances to Suppliers |
85,321,166.48 |
| Other Receivables |
6,179,049.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
351,390,419.85 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,768,051.84 |
| Total Current Assets |
998,356,211.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
112,453,802.65 |
| Fixed Assetes |
264,428,655.73 |
| Under-construction Projects |
93,622,180.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,083,884.62 |
| R&D expenses |
735,436.76 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,046,450.74 |
| Deferred Income Tax Assets |
8,134,322.22 |
| Other Non-Current Assets |
54,211,459.49 |
| Sub-Total of Non-Current Assets |
564,904,187.99 |
| Total Assets |
1,563,260,399.00 |
| Short-Term Loans |
60,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,080,162.19 |
| Accounts Payable |
243,667,394.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,684,876.66 |
| Taxes Payable |
4,507,255.16 |
| Interest Payable |
75,107.52 |
| Dividend Payable |
899,726.22 |
| Other payables |
25,639,692.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,506,901.43 |
| Other Current Liabilities |
159,558,482.59 |
| Sub-Total of Current Liabilities |
543,188,564.31 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,446,416.04 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,464,387.30 |
| Total Liabilities |
552,652,951.61 |
| Paid-In Capital(Or Share Stock) |
577,595,483.00 |
| Capital Surplus |
647,246,492.54 |
| Surplus Reserve |
22,597,155.76 |
| LESS:Treasury Stock |
15,158,403.00 |
| Undistributed Profits |
-235,727,996.74 |
| Minority Stockholder's Interest |
10,042,975.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,000,564,471.66 |
| Owner's Equity（Stockholder's Equity） |
1,010,607,447.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,563,260,399.00 |
